Draft genome data analysis and pathogenicity profiling of Staphylococcus aureus strain IHS3A with antibiotic resistance genes isolated from a hospital in Jordan

This dataset provides a comprehensive genomic and pathogenicity profiling of <i>Staphylococcus aureus</i> strain IHS3A, a methicillin-resistant (MRSA) clinical isolate obtained from a healthcare worker in a teaching hospital in Jordan, Middle East. Whole genome sequencing was performed using the Illumina NextSeq 2000 platform, followed by high-quality de novo assembly using SPAdes. The genome spans 2821,373 bp across 90 contigs, with a GC content of 32.78%, and demonstrates high-quality metrics, including 99.67% completeness and minimal contamination (0.08%). The genome analysis identified 2611 predicted protein-coding sequences. Multilocus sequence typing (MLST) assigned the isolate to ST10647, SCC<i>mec</i> typing revealed type IVc (2B), and spa typing identified t131. The dataset includes comprehensive annotations of key antimicrobial resistance genes, such as <i>mecA</i> (methicillin resistance), <i>blaZ</i> (penicillin resistance), and <i>lmrS</i> (macrolide efflux), as well as virulence factors related to adherence (e.g., <i>atl, clfA</i>), immune evasion (e.g., <i>scn, adsA</i>), secretion systems (e.g., <i>esaA, esaB</i>), and toxins (e.g., <i>hla, lukF</i>-<i>PV, tsst</i>). Secondary metabolite biosynthetic gene clusters, such as staphyloferrin B and staphylopine, were identified. The genome also encodes a diverse carbohydrate-active enzyme (CAZyme) profile. These genomic data are valuable for further research on MRSA evolution, resistance mechanisms, and virulence factors in Jordan and the Middle East. The genome data have been deposited in the NCBI database under the accession number JBPPGA000000000, with a direct URL to data: https://www.ncbi.nlm.nih.gov/nuccore/JBPPGA000000000.1. Bioproject: PRJNA1283614, Biosample: SAMN49700843.